相似文献
1
Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
Antimicrob Agents Chemother. 1999 Dec;43(12):3030-2. doi: 10.1128/AAC.43.12.3030.
2
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
Infection. 1996 Jan-Feb;24(1):60-3. doi: 10.1007/BF01780660.
3
In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone.
Antimicrob Agents Chemother. 1992 Aug;36(8):1788-90. doi: 10.1128/AAC.36.8.1788.
4
Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
J Chemother. 2000 Dec;12(6):503-8. doi: 10.1179/joc.2000.12.6.503.
5
Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
Infection. 1996 Jan-Feb;24(1):9-16. doi: 10.1007/BF01780643.
6
Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.
Cent Eur J Public Health. 2001 Feb;9(1):38-40.
7
In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.
J Clin Microbiol. 2003 Apr;41(4):1791-3. doi: 10.1128/JCM.41.4.1791-1793.2003.
8
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.
Antimicrob Agents Chemother. 2001 Sep;45(9):2486-94. doi: 10.1128/AAC.45.9.2486-2494.2001.
9
10
Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
Int J Antimicrob Agents. 2000 Jun;15(1):11-7. doi: 10.1016/s0924-8579(00)00116-3.
引用本文的文献
1
The In Vitro Antimicrobial Susceptibility of sensu lato: Shedding Light on the Known Unknowns.
Pathogens. 2023 Sep 28;12(10):1204. doi: 10.3390/pathogens12101204.
2
Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.
mBio. 2022 Jun 28;13(3):e0344021. doi: 10.1128/mbio.03440-21. Epub 2022 Apr 25.
3
Generality of Post-Antimicrobial Treatment Persistence of Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains.
Infect Immun. 2019 Sep 19;87(10). doi: 10.1128/IAI.00442-19. Print 2019 Oct.
4
Persistence of Borrelia burgdorferi following antibiotic treatment in mice.
Antimicrob Agents Chemother. 2008 May;52(5):1728-36. doi: 10.1128/AAC.01050-07. Epub 2008 Mar 3.
5
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.
Wien Klin Wochenschr. 2006 Nov;118(21-22):659-68. doi: 10.1007/s00508-006-0693-z.
6
In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.
Antimicrob Agents Chemother. 2001 Sep;45(9):2486-94. doi: 10.1128/AAC.45.9.2486-2494.2001.
本文引用的文献
1
In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.
Antimicrob Agents Chemother. 1993 Jul;37(7):1444-6. doi: 10.1128/AAC.37.7.1444.
2
Isolation of Borrelia burgdorferi from myocardium.
Lancet. 1993 Aug 21;342(8869):490. doi: 10.1016/0140-6736(93)91612-p.
3
Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons.
Int J Syst Bacteriol. 1994 Oct;44(4):743-52. doi: 10.1099/00207713-44-4-743.
4
In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi.
Antimicrob Agents Chemother. 1995 May;39(5):1185-6. doi: 10.1128/AAC.39.5.1185.
5
Use of polymerase chain reaction and specific monoclonal antibodies as rapid method to recognize Borrelia burgdorferi sensu stricto, B. garinii and B. afzelii among Italian isolates of B. burgdorferi.
Med Microbiol Immunol. 1994 Dec;183(6):307-13. doi: 10.1007/BF00196681.
6
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.
Antimicrob Agents Chemother. 1987 Feb;31(2):164-7. doi: 10.1128/AAC.31.2.164.
7
Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
Infection. 1989 Nov-Dec;17(6):355-9. doi: 10.1007/BF01645543.
8
[Borrelia burgdorferi infection. I. Aspects of basic research, current approach for diagnosis and therapy].
Hautarzt. 1990 Dec;41(12):648-57.
9
The in-vitro activity of cefodizime: a review.
J Antimicrob Chemother. 1990 Nov;26 Suppl C:13-21. doi: 10.1093/jac/26.suppl_c.13.
10
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
Antimicrob Agents Chemother. 1990 Nov;34(11):2133-6. doi: 10.1128/AAC.34.11.2133.
Zotero 插件